Rating History for 9/14/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics
(Cantor Fitzgerald - Joshua Schimmer) |
FDMT | Upgrade | Overweight (Neutral) |
N/A (N/A) |
13.17 (14.56) |
10.55% | Details | ||
| AAR Corporation
(Guggenheim - Michael Ciarmoli) |
AIR | New Coverage | Neutral (N/A) |
N/A (N/A) |
125.48 (115.09) |
-8.28% | Details | ||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 218 more... | |||||||||
